Literature DB >> 10219845

Local and systemic liberation of proinflammatory cytokines in ulcerative colitis.

M Gotteland1, M Lopez, C Muñoz, R Saez, H Altshiller, P Llorens, O Brunser.   

Abstract

Determination of plasma and tissue cytokine levels in inflammatory bowel disease have frequently resulted in conflicting data. In the present study we determined in patients with ulcerative colitis (UC), the levels of the proinflammatory cytokines interleukin (IL)-1beta, IL-6, interferon (IFN)-gamma, and tumor-necrosis factor (TNF)-alpha liberated by peripheral blood mononuclear cells (PBMC) and lamina propria mononuclear cells (LPMC) after 48-hr culture with pokeweed mitogen (PWM). IL-1beta, IL-6, IFN-gamma and TNF-alpha in the supernatant were detected by ELISA. Results show low basal levels of IL-1beta secretion by PBMC and LPMC, and a considerable increase after mitogen stimulation. Basal IL-6 production by PBMC was higher in UC patients than in controls [2029 pg/ml, CI95(-165 to 4223) vs 572 pg/ml (-383 to 1527) respectively, P = 0.05] and also after PWM activation [14,995 pg/ml (7759-22,230) vs 6598 pg/ml (3240-9956), respectively, P = 0.05]. In LPMC, no differences in IL-6 secretion were observed. TNF-alpha in activated PBMC of patients with UC was not significantly increased in relation to control (P = 0.09). No constitutive secretion of IFN-gamma was observed in mononuclear cells. IFN-gamma levels secreted by activated LPMC were lower in patients with UC than in controls [1571 pg/ml (-108 to 3251) vs 7953 pg/ml (3851-12,055), respectively, P = 0.03]. These results suggest that IL-6, IL-1beta, and TNF-alpha participate as mediators in the inflammatory phenomena observed in UC. Further studies are necessary to evaluate the role of IFN-gamma in this condition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10219845     DOI: 10.1023/a:1026690631693

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  34 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor.

Authors:  X M Sun; W Hsueh
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

3.  Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls.

Authors:  K Kusugami; K R Youngman; G A West; C Fiocchi
Journal:  Gastroenterology       Date:  1989-07       Impact factor: 22.682

4.  Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine.

Authors:  T T MacDonald; P Hutchings; M Y Choy; S Murch; A Cooke
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

Review 5.  Cytokines in intestinal inflammation: pathophysiological and clinical considerations.

Authors:  R B Sartor
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

6.  Mucosal factors inducing neutrophil movement in ulcerative colitis: the role of interleukin 8 and leukotriene B4.

Authors:  A T Cole; B J Pilkington; J McLaughlan; C Smith; M Balsitis; C J Hawkey
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

7.  Mucosal interleukin-6 secretion in ulcerative colitis. Effects of anti-inflammatory drugs and T-cell stimulation.

Authors:  S C Jones; J E Crabtree; B J Rembacken; M F Dixon; L K Trejdosiewicz; J T Whicher; A T Axon
Journal:  Scand J Gastroenterol       Date:  1994-08       Impact factor: 2.423

8.  Expression of HLA-DR antigens in inflammatory bowel disease mucosa: role of intestinal lamina propria mononuclear cell-derived interferon gamma.

Authors:  O Y Qin; M el-Youssef; B Yen-Lieberman; W Sapatnekar; K R Youngman; K Kusugami; C Fiocchi
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

9.  Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR).

Authors:  M Niessner; B A Volk
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

10.  Antibodies against Mycobacterium paratuberculosis in Crohn's disease.

Authors:  R S Walmsley; J P Ibbotson; H Chahal; R N Allan
Journal:  QJM       Date:  1996-03
View more
  12 in total

1.  A coculture model mimicking the intestinal mucosa reveals a regulatory role for myofibroblasts in immune-mediated barrier disruption.

Authors:  L E M Willemsen; C C H M Schreurs; H Kroes; E J Spillenaar Bilgen; S J H Van Deventer; E A F Van Tol
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

2.  Rectal nitric oxide as biomarker in the treatment of inflammatory bowel disease: responders versus nonresponders.

Authors:  Tryggve Ljung; Sofie Lundberg; Mark Varsanyi; Catharina Johansson; Peter T Schmidt; Max Herulf; Jon O Lundberg; Per M Hellstrom
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

3.  Distinct Methylation of IFNG in the Gut.

Authors:  Rivkah Gonsky; Richard L Deem; Stephan R Targan
Journal:  J Interferon Cytokine Res       Date:  2009-07       Impact factor: 2.607

4.  Critical comment: analyzing the effect of novel therapies on cytokine expression in inflammatory bowel disease: do cytokine levels reflect clinical response?

Authors:  B M Wittig; M Zeitz
Journal:  Int J Colorectal Dis       Date:  2006-01-17       Impact factor: 2.571

Review 5.  IBS and IBD - separate entities or on a spectrum?

Authors:  Robin Spiller; Giles Major
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-26       Impact factor: 46.802

6.  Macrophage migration inhibitory factor activates antigen-presenting dendritic cells and induces inflammatory cytokines in ulcerative colitis.

Authors:  H Murakami; S M F Akbar; H Matsui; N Horiike; M Onji
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

Review 7.  Regulatory T cells in inflammatory bowel diseases and colorectal cancer.

Authors:  Györgyi Műzes; Béla Molnár; Ferenc Sipos
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

Review 8.  Critical role of nociceptor plasticity in chronic pain.

Authors:  David B Reichling; Jon D Levine
Journal:  Trends Neurosci       Date:  2009-09-24       Impact factor: 13.837

9.  The production of interferon-gamma-inducible protein 10 by granulocytes and monocytes is associated with ulcerative colitis disease activity.

Authors:  Atsushi Noguchi; Kenji Watanabe; Shosaku Narumi; Hirokazu Yamagami; Yasuhiro Fujiwara; Kazuhide Higuchi; Nobuhide Oshitani; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2007-12-25       Impact factor: 7.527

10.  Transcript levels of different cytokines and chemokines correlate with clinical and endoscopic activity in ulcerative colitis.

Authors:  Alexandra Zahn; Thomas Giese; Max Karner; Annika Braun; Ulf Hinz; Wolfgang Stremmel; Robert Ehehalt
Journal:  BMC Gastroenterol       Date:  2009-02-09       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.